Erica F. Bonazzina

Milan, 20162, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohort.

Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohort.

Journal: Scientific reports

Published: March 12, 2026

Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study.

Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management.

Locally advanced rectal cancer: what patients and practitioners should know about non-operative management.

Journal: EClinicalMedicine

Published: December 22, 2025

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.

Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies.

Journal: Drugs

Published: September 08, 2025

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: May 15, 2025

Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset.

Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset.

Journal: ESMO open

Published: April 11, 2025

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.

A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection.

Journal: Diagnostics (Basel, Switzerland)

Published: September 11, 2024

Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.

Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.

Journal: Journal of clinical pathology

Published: December 09, 2023

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.

Journal: Clinical colorectal cancer

Published: September 14, 2023

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer.

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 15, 2023

Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.

Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.

Journal: BMJ supportive & palliative care

Published: February 03, 2023

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.

Journal: Frontiers in oncology

Published: January 18, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026